AbbVie reports third-quarter 2014 financial results
AbbVie reported Worldwide sales were $5.019 billion in the 2014 third quarter, up 7.8 percent versus the prior year period, and 2014 third-Quarter adjusted EPS of $0.89, up 8.5 Percent and well above the previous guidance range of $0.77 to $0.79. October 31, 2014